Status:

RECRUITING

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Lead Sponsor:

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborating Sponsors:

TransAtlantic Retroperitoneal Sarcoma Working Group

Conditions:

Retroperitoneal Sarcoma

Eligibility:

All Genders

18+ years

Brief Summary

Surgery is currently the only potentially curative treatment modality for localized retroperitoneal sarcoma (RPS). Available studies regarding oncologic outcomes are mainly retrospective in nature, an...

Detailed Description

Retroperitoneal sarcomas (RPS) are rare tumors accounting for 10-15% of all soft tissue sarcomas (STS). They arise between retroperitoneal organs and among vital structures (ie major abdominal vessels...

Eligibility Criteria

Inclusion

  • primary RPS operated on in the participating center;
  • age\>18 years at the time of the first treatment (pediatric patients can not be included)
  • histological confirmed diagnosis according to the WHO criteria done on biopsy or surgical specimen by dedicated sarcoma pathologist;
  • radiological examinations performed (contrast enhanced abdominal CT scan and/or MRI) prior to surgical resection;
  • signed informed consent form;
  • adequate compliance of the patients to the plan of follow-up

Exclusion

  • age\<18 years;
  • recurrent tumor;
  • benign retroperitoneal tumors;
  • serious psychiatric disease that precludes informed consent or limits compliance;
  • impossibility to ensure adequate follow-up

Key Trial Info

Start Date :

September 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2030

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT03838718

Start Date

September 1 2016

End Date

December 31 2030

Last Update

February 12 2019

Active Locations (22)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (22 locations)

1

University of Southern California (USC)

Los Angeles, California, United States, 90033

2

Mayo Clinic

Jacksonville, Florida, United States, 32224

3

Moffitt Cancer Center

Tampa, Florida, United States, 33612

4

Winship Cancer Institute

Emory, Georgia, United States, 30322

REtroperitoneal SArcoma Registry: an International Prospective Initiative | DecenTrialz